# HCA Healthcare, Inc. (HCA) · Edgar & Edgarette company card

> HCA Healthcare (HCA) grew revenue 7.1% in FY2025 to $75.6 billion, equity -9.9% of assets, and dividend per share up 5 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 860730 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HCA) · [JSON](https://www.pops4.com/boards/company/HCA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $75.6B |
| Revenue growth, 1 year | 7.1% |
| Revenue growth per year | 6.5% |
| Operating margin | — |
| Net margin | 10.3% |
| Operating cash flow | $12.6B |
| Capital spending | $4.9B |
| Free cash flow | $7.7B |
| Cash | $1.0B |
| Long-term debt | $44.3B |
| Total assets | $60.7B |
| Total equity | −$6.0B |
| Equity ÷ assets | -9.9% |
| Return on equity | — |
| Dividend per share | $2.88 |
| Dividend years rising | 5 |

## Readings, computed from those figures

- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · liabilities exceed assets (often from years of share buybacks, not always distress)
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $75.6B (FY2025), total debt $44.3B. Experience: revenue up 7.1% on the year, up 6.5% a year over 4 years. Soundness: equity -9.9% of assets (liabilities exceed assets), payout 8.7% of profit, dividend per share up 5 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $73.4B and $84.2B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $69.1B to $89.0B. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): growth 7.1% against 13.0%.

Range logged 2026-09-26, receipt 12c486ada0c51dda, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-06-18 ([filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526275086/0001193125-26-275086-index.htm))

## Recent filings

- 8-K · filed 2026-11-05 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526449922/0001193125-26-449922-index.htm)
- 8-K · filed 2026-11-02 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526443864/0001193125-26-443864-index.htm)
- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526437871/0001193125-26-437871-index.htm)
- 8-K · filed 2026-10-27 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526432665/0001193125-26-432665-index.htm)
- 8-K · filed 2026-07-29 · 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526323731/0001193125-26-323731-index.htm)
- 10-Q · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/860730/000119312526321077/0001193125-26-321077-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000860730.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=860730

## Cite

POPS4, Edgar & Edgarette: HCA Healthcare, Inc. (HCA) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/HCA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.